00000000|MMI|40.35|Adverse reactions|C0559546|[patf]|["Adverse reactions"-tx-14-"Adverse Reactions"-noun-0,"Adverse reactions"-tx-14-"adverse reactions"-noun-0,"ADVERSE REACTION"-tx-10-"adverse reaction"-noun-0,"ADVERSE REACTION"-tx-3-"adverse reaction"-noun-0,"ADVERSE REACTION"-tx-2-"adverse reaction"-noun-0,"Adverse reactions"-tx-2-"ADVERSE REACTIONS"-noun-0,"ADVERSE REACTION"-tx-1-"adverse reaction"-noun-0,"Adverse reactions"-tx-1-"ADVERSE REACTIONS"-noun-0,"Adverse reactions"-tx-1-"adverse reactions"-noun-0]|TX|3100/17;3128/17;2499/16;1230/16;941/16;1014/17;691/16;6/17;59/17|
00000000|MMI|39.80|Leukocytosis|C0023518|[patf]|["Leucocytosis"-tx-13-"leukocytosis"-noun-1,"Leucocytosis"-tx-12-"Leukocytosis"-noun-0,"Leucocytosis"-tx-12-"leukocytosis"-noun-0]|TX|3037/12;2830/12;2870/12|C15.378.553.475;C23.550.526
00000000|MMI|39.64|Breast Carcinoma|C0678222|[neop]|["Cancer of the Breast"-tx-8-"of the breast cancer"-noun-0,"Breast Cancer"-tx-5-"breast cancer"-noun-0,"Breast Cancer"-tx-4-"breast cancer"-noun-0]|TX|2074/20;1672/13;1587/13|C04.588.180;C17.800.090.500
00000000|MMI|32.84|Lymphoma, Non-Hodgkin|C0024305|[neop]|["Lymphoma, Nonhodgkin's"-tx-7-"non-Hodgkin's lymphoma"-noun-0,"Lymphoma, Nonhodgkin's"-tx-4-"non-Hodgkin's lymphoma"-noun-0]|TX|1912/22;1634/22|C04.557.386.480;C15.604.515.569.480;C20.683.515.761.480
00000000|MMI|29.46|Sweet Syndrome|C0085077|[dsyn]|["Acute febrile neutrophilic dermatosis"-tx-14-"acute febrile neutrophilic dermatosis"-noun-0,"SWEET SYNDROME"-tx-14-"Sweet's syndrome"-noun-0]|TX|3289/37;3271/16|C17.800.229.800
00000000|MMI|20.95|Anemia, Sickle Cell|C0002895|[dsyn]|["Cell Disease, Sickle"-tx-1-"Sickle Cell Disease"-noun-0]|TX|396/19|C15.378.071.141.150.150;C15.378.420.155;C16.320.070.150;C16.320.365.155
00000000|MMI|20.95|Myalgia|C0231528|[sosy]|["MYALGIA"-tx-14-"myalgia"-noun-0]|TX|3242/7|C05.651.542;C10.597.617.231.249;C10.668.491.525;C23.888.592.612.547.249;F02.830.816.353.500;G11.561.600.810.353.500
00000000|MMI|17.80|Headache|C0018681|[sosy]|["HEADACHE"-tx-14-"headache"-noun-0]|TX|3251/8|C10.597.617.470;C23.888.592.612.441
00000000|MMI|15.51|Bone Pain Adverse Event|C1963077|[fndg]|["Bone pain"-tx-11-"bone pain"-noun-0,"Bone pain"-tx-10-"Bone pain"-noun-0,"Bone pain"-tx-2-"bone pain"-noun-0,"Bone pain"-tx-1-"bone pain"-noun-0]|TX|2711/9;2448/9;971/9;894/9|
00000000|MMI|15.51|Bone pain|C0151825|[sosy]|["BONE PAIN"-tx-11-"bone pain"-noun-0,"BONE PAIN"-tx-10-"Bone pain"-noun-0,"BONE PAIN"-tx-2-"bone pain"-noun-0,"BONE PAIN"-tx-1-"bone pain"-noun-0]|TX|2711/9;2448/9;971/9;894/9|
00000000|MMI|14.64|Splenic Rupture|C0038000|[inpo]|["SPLENIC RUPTURE"-tx-1-"Splenic Rupture"-noun-0]|TX|149/15|C15.604.744.742;C26.017.680;C26.761.555
00000000|MMI|14.64|Thrombocytopenia|C0040034|[fndg]|["Thrombocytopaenia"-tx-14-"thrombocytopenia"-noun-0]|TX|3354/16|C15.378.140.855
00000000|MMI|14.64|Vomiting|C0042963|[sosy]|["VOMITING"-tx-14-"vomiting"-verb-0]|TX|3261/8|C23.888.821.937
00000000|MMI|11.49|Capillary Leak Syndrome|C0343084|[dsyn]|["CAPILLARY LEAK SYNDROME"-tx-1-"Capillary Leak Syndrome"-noun-0]|TX|465/23|C14.907.218
00000000|MMI|11.49|Complication Aspects|C1171258|[patf]|["complications"-tx-13-"complications"-noun-1]|TX|3007/13|x.x.x
00000000|MMI|11.49|Respiratory Distress Syndrome, Adult|C0035222|[dsyn]|["Acute Respiratory Distress Syndrome"-tx-1-"Acute Respiratory Distress Syndrome"-noun-0]|TX|214/35|C08.381.840;C08.618.840
00000000|MMI|10.96|White blood cell count increased (lab result)|C0750426|[fndg]|["Leukocytosis"-tx-13-"leukocytosis"-noun-1,"Leukocytosis"-tx-12-"Leukocytosis"-noun-0,"Leukocytosis"-tx-12-"leukocytosis"-noun-0]|TX|3037/12;2830/12;2870/12|
00000000|MMI|10.80|Malignant neoplasm of breast|C0006142|[neop]|["Cancer of the Breast"-tx-8-"of the breast cancer"-noun-0,"-- Breast Cancer"-tx-5-"breast cancer"-noun-0,"-- Breast Cancer"-tx-4-"breast cancer"-noun-0]|TX|2074/20;1672/13;1587/13|
00000000|MMI|9.84|Disease|C0012634|[dsyn]|["condition"-tx-3-"conditions"-noun-0]|TX|1218/10|C23.550.288
00000000|MMI|7.42|3-4|C3840617|[fndg]|["3-4"-tx-11-"3.4"-percentage-0]|TX|[2749/3],[2755/3]|
00000000|MMI|7.42|3/4|C0442757|[fndg]|["3 4"-tx-11-"3.4"-percentage-0]|TX|[2749/3],[2755/3]|
00000000|MMI|7.42|Carcinoma of lung|C0684249|[neop]|["-- Lung Cancer"-tx-6-"lung cancer"-noun-0,"-- Lung Cancer"-tx-4-"lung cancer"-noun-0]|TX|1794/11;1610/11|
00000000|MMI|7.42|Malignant neoplasm of lung|C0242379|[neop]|["Lung Cancer"-tx-6-"lung cancer"-noun-0,"Lung Cancer"-tx-4-"lung cancer"-noun-0]|TX|1794/11;1610/11|
00000000|MMI|7.42|Primary malignant neoplasm of lung|C1306460|[neop]|["Lung cancer"-tx-6-"lung cancer"-noun-0,"Lung cancer"-tx-4-"lung cancer"-noun-0]|TX|1794/11;1610/11|
00000000|MMI|6.94|1+|C3816745|[fndg]|["1+"-tx-12-"1"-percentage-1,"1+"-tx-11-"1"-percentage-0]|TX|2944/1;2768/1|
00000000|MMI|6.91|Allergic Reaction|C1527304|[patf]|["Reactions, Allergic"-tx-1-"Allergic Reactions"-noun-0]|TX|307/18|C20.543
00000000|MMI|6.91|Hypersensitivity|C0020517|[patf]|["Allergic reactions"-tx-1-"Allergic Reactions"-noun-0]|TX|307/18|C20.543
00000000|MMI|5.18|5-6|C3843715|[fndg]|["5-6"-tx-1-"5.6"-real_number-0]|TX|642/3|
00000000|MMI|5.18|6/5|C0442749|[fndg]|["5 6"-tx-1-"5.6"-real_number-0]|TX|642/3|
00000000|MMI|5.18|Complication|C0009566|[patf]|["Complications"-tx-13-"complications"-noun-1]|TX|3007/13|
00000000|MMI|5.18|ENT surgical result nose headache|C2096315|[fndg]|["headache"-tx-14-"headache"-noun-0]|TX|3251/8|
00000000|MMI|5.18|Vasculitis of the skin|C0262988|[dsyn]|["Cutaneous Vasculitis"-tx-14-"cutaneous vasculitis"-noun-0]|TX|3329/20|
00000000|MMI|5.18|Vomiting Adverse Event|C1963281|[patf]|["Vomiting"-tx-14-"vomiting"-verb-0]|TX|3261/8|
00000000|MMI|3.61|10%|C3842590|[fndg]|["10%"-tx-12-"10"-integer-0]|TX|2907/2|
00000000|MMI|3.59|80%|C3842583|[fndg]|["80%"-tx-6-"80"-percentage-0]|TX|1813/2|
00000000|MMI|3.59|One day|C3844320|[fndg]|["One day"-tx-9-"one day"-noun-0]|TX|2291/7|
00000000|MMI|3.59|Used by|C1273517|[fndg]|["used"-tx-8-"used"-verb-1]|TX|2152/4|
00000000|MMI|3.58|Administered subcutaneously|C1736929|[fndg]|["Administered subcutaneously"-tx-9-"administered subcutaneously"-verb-1]|TX|2230/12,2255/14|
00000000|MMI|3.51|Experimental Result|C2825142|[fndg]|["Result"-tx-4-"results"-noun-0]|TX|1490/7|
00000000|MMI|3.50|50%|C3842586|[fndg]|["50%"-tx-5-"50"-integer-0]|TX|1741/2|
00000000|MMI|3.50|<50|C3843766|[fndg]|["<50"-tx-5-"50"-integer-0]|TX|1741/2|
00000000|MMI|3.45|tumor growth|C0598934|[neop]|["tumor growth"-tx-1-"Tumor Growth"-noun-0]|TX|556/12|
00000000|MMI|3.43|Myeloid neoplasm|C2939461|[neop]|["Myeloid Malignancy"-tx-12-"myeloid malignancies"-noun-1]|TX|2965/20|
